A carregar...
Dasatinib-induced chylothorax in chronic myeloid leukemia
Pulmonary adverse events are common abnormalities associated with the use of dasatinib in chronic myeloid leukemia. We present a case of a 69-year-old man who suddenly developed a rare chylothorax pulmonary adverse event following 10 months of dasatinib treatment.
Na minha lista:
Publicado no: | Proc (Bayl Univ Med Cent) |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Baylor Health Care System
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5242121/ https://ncbi.nlm.nih.gov/pubmed/28127140 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|